Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2008
08/21/2008WO2008099016A2 Method for stabilising blood plasma components in a lyophilisate
08/21/2008WO2008098969A1 Pharmaceutical compositions containing quetiapine fumarate
08/21/2008WO2008098780A1 Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
08/21/2008WO2008098760A2 Solid pharmaceutical formulations of a homogeneous dispersion of active principles having ph-dependent solubility
08/21/2008WO2008098750A1 Pharmaceutical carrier composition and pharmaceutical composition
08/21/2008WO2008098634A1 Dermal film-forming liquid formulations for drug release to skin
08/21/2008WO2008098586A1 Pharmaceutical carrier composition and pharmaceutical composition
08/21/2008WO2008098427A1 Use of ethyl piperic acid ester in preparation of medicament or healthcare product for the prevention and/or treatment of atherosclerosis
08/21/2008WO2008098415A1 Pharmaceutical composition containing taxane and its preparation process and application
08/21/2008WO2008098364A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
08/21/2008WO2008085310A3 Effervescent formulations of florfenicol for addition in drinking water systems
08/21/2008WO2008083158A3 Topical administration of danazol
08/21/2008WO2008083092A3 Polynuclear microcapsules
08/21/2008WO2008079806A3 Treated substrates having improved delivery of impregnated ingredients
08/21/2008WO2008079629A3 Formulations with improved bioavailability
08/21/2008WO2008077130A3 Homogeneous paste and gel formulations
08/21/2008WO2008075321A3 Modified-release formulations of azabicyclo derivatives
08/21/2008WO2008072270A3 Method for producing a proteic net able to trap nutrients and/or pharmacologically active substances
08/21/2008WO2008061874A3 Stable powder formulation containing an anticholinergic agent
08/21/2008WO2008055146A9 Formulations of phospholipase enzyme inhibitors
08/21/2008WO2008055032A3 Methods and devices to test diffusion rates of ocular drug delivery systems
08/21/2008WO2008052766A3 Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases
08/21/2008WO2008044236B1 Improved release of statins in the intestine
08/21/2008WO2007121083A3 Thickened dilute hypochlorite
08/21/2008WO2007103638A3 Hormone replacement formulation
08/21/2008WO2007103276A3 Systems and methods for delivering a medicament
08/21/2008WO2007072022A3 Composition comprising an antigen-recognizing molecule and a lipid-based carrier
08/21/2008US20080200750 Polymer encapsulation for medical device
08/21/2008US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
08/21/2008US20080200417 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
08/21/2008US20080200394 Treatment of Inflammatory Airway Disease
08/21/2008US20080199957 therapeutic or diagnostic agent is covalently coupled to the transport agent, which is poly(2-ethylacrylic acid), poly(2-propylacrylic acid), poly(2-butylacrylic acid); drug delivery of proteins, DNA, nucleotides through endosomal membrane
08/21/2008US20080199534 Mixture containing metal compound and oxidizable vitamin; stabilization
08/21/2008US20080199531 Methods And Products For Delivering Biological Molecules To Cells Using Multicomponent Nanostructures
08/21/2008US20080199530 Abuse-deterrent pharmaceutical compositions of opioids and other drugs
08/21/2008US20080199529 Nanoparticle delivery vehicle
08/21/2008US20080199528 Colonic delivery of metallo-dependent enzymes
08/21/2008US20080199527 sustained release; coated with polymer
08/21/2008US20080199524 Eyedrops containing particulate agar
08/21/2008US20080199523 Particles Comprising A Releasable Dopant Therein
08/21/2008US20080199522 Timed-release compression-coated solid composition for oral administration
08/21/2008US20080199521 Controlled release compressed tablet; cardiovascular disorders; antidiabetic agents; analgesics; thrombosis
08/21/2008US20080199520 Cognition activators; antiaging agent;veterinary medicine
08/21/2008US20080199519 Production of Double-or Multi-Layered Microcapsules
08/21/2008US20080199518 Using 5-fluoro-8-94-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; sustained release bead; core containing drug and multilayer overcoatings; cognition activators; anxiolytic agents; Parkinson's, Huntington's, Alzheimer's disease; psychological disorders
08/21/2008US20080199517 Composition and a process thereof
08/21/2008US20080199516 Encapsulation Of Lipid-Based Formulations In Enteric Polymers
08/21/2008US20080199515 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
08/21/2008US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy
08/21/2008US20080199513 Systems and methods for preparing autologous fibrin glue
08/21/2008US20080199512 Oral Composition For Moisturizing Skin
08/21/2008US20080199511 Sustained Release Compositions Containing Progesterone Receptor Modulators
08/21/2008US20080199509 Preventing, reducting biofilms by administering charged polyamino acid; antiinflammatory agents; respiratory system disorders
08/21/2008US20080199508 Containing polyglycan and mucopolysaccharides with polypeptides; improve performance of medical device
08/21/2008US20080199503 Mixture of oligopeptide and cyclodextrins; model for drug design ; hypotensive agenst; cardiovascular disorders; atherosclerosis; antitumor agenst; antidiabetic agenst
08/21/2008US20080199501 Cosmetics; water insoluble substrate impregnated with cosmetics; mixture of water, oil and semi-crystalline polymer; wipe for skin, hair; cleaning compound
08/21/2008US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections
08/21/2008US20080199448 Enzyme composition for improving food digestion
08/21/2008US20080199410 Pulmonary surfactant formulations and methods for promoting mucus clearance
08/21/2008US20080199409 Effervescent Acidified Rehydration Preparations
08/21/2008US20080199406 Tablet comprising one or more predetermined three-dimensional structures on its surface or below a coating vertical direction; invisible to unaided eye; detectable by optical interferometry microscopy; counterfeiting prevention
08/21/2008US20080199400 Otologic nanotechnology
08/21/2008DE102007008484A1 Pharmazeutische Zubereitung zur Bekämpfung von Metastasen Pharmaceutical composition for controlling metastases
08/21/2008CA2713977A1 Methods and compositions for the disruption of biofilms
08/21/2008CA2678535A1 Controlled-release preparation containing cilostazol and process for the preparation thereof
08/21/2008CA2678515A1 Use of ranolazine for the treatment of cardiovascular diseases
08/21/2008CA2678500A1 Compositions and methods for enhancing transmucosal delivery
08/21/2008CA2678482A1 Controlled release preparation containing cilostazol and process for the preparation thereof
08/21/2008CA2678480A1 Thixotropic pharmaceutical compositions
08/21/2008CA2678325A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
08/21/2008CA2678319A1 Use of ranolazine for the treatment of coronary microvascular diseases
08/21/2008CA2678176A1 Sustained delivery formulations of rapamycin compounds
08/21/2008CA2678151A1 Broad-spectrum antiviral composition with excellent preservation stability
08/21/2008CA2678066A1 Polymer-based films and drug delivery systems made therefrom
08/21/2008CA2678020A1 Method for production of radiation diagnostic imaging agent
08/21/2008CA2678013A1 Lung cancer-targeted peptides and applications thereof
08/21/2008CA2677937A1 Use of sucrose to suppress mannitol-induced protein aggregation
08/21/2008CA2677931A1 Use of ranolazine for the treatment of cardiovascular diseases
08/21/2008CA2677856A1 Pharmaceutical carrier composition and pharmaceutical composition
08/21/2008CA2677842A1 Pharmaceutical composition comprising microparticle oily suspension
08/21/2008CA2677281A1 Transoral dosage forms comprising sufentanil and naloxone
08/21/2008CA2676684A1 Solid pharmaceutical formulations of a homogeneous dispersion of active principles having ph-dependent solubility
08/21/2008CA2676607A1 Improved stability in vitamin and mineral supplements
08/21/2008CA2675793A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
08/21/2008CA2675602A1 Protein formulations containing sorbitol
08/21/2008CA2675601A1 Ophthalmic compositions containing a synergistic combination of three polymers
08/21/2008CA2675568A1 Dermal film-forming liquid formulations for drug release to skin
08/21/2008CA2621452A1 Stent and method for reducing tissue damage after ischemic injury with thymosin b4
08/20/2008EP1959466A2 Photovoltaic fibers
08/20/2008EP1958963A1 Oxygen-carrying blood substitute preparations
08/20/2008EP1958949A1 Therapeutic agent for corneal/conjuctival disease
08/20/2008EP1958707A1 Mechanically responsive supported polyelectrolyte multilayer films
08/20/2008EP1958635A1 Treatment
08/20/2008EP1958629A1 A transdermal fluid comprising tocotrienol
08/20/2008EP1958628A1 Combination of immediately liberated drospirenone with a modified releasing formulation containing 8-prenylnaringenin for use in oral contraception and hormone replacement therapy
08/20/2008EP1958625A1 Enteric coate bead comprising ixabepilone and preparation thereof
08/20/2008EP1958624A1 Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
08/20/2008EP1958623A1 Poly(Lactide-Co-Glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
08/20/2008EP1958622A1 Method of producing microcapsules
08/20/2008EP1958621A2 Drug detoxification protocol using microdosing
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 2991